These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26802037)

  • 1. Primary immunodeficiencies worldwide: an updated overview from the Jeffrey Modell Centers Global Network.
    Modell V; Quinn J; Orange J; Notarangelo LD; Modell F
    Immunol Res; 2016 Jun; 64(3):736-53. PubMed ID: 26802037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician reported outcomes.
    Modell V; Orange JS; Quinn J; Modell F
    Immunol Res; 2018 Jun; 66(3):367-380. PubMed ID: 29744770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery.
    Modell V; Knaus M; Modell F; Roifman C; Orange J; Notarangelo LD
    Immunol Res; 2014 Oct; 60(1):132-44. PubMed ID: 24668296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth in diagnosis and treatment of primary immunodeficiency within the global Jeffrey Modell Centers Network.
    Quinn J; Modell V; Orange JS; Modell F
    Allergy Asthma Clin Immunol; 2022 Mar; 18(1):19. PubMed ID: 35246253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling strategy to identify patients with primary immunodeficiency utilizing risk management and outcome measurement.
    Modell V; Quinn J; Ginsberg G; Gladue R; Orange J; Modell F
    Immunol Res; 2017 Jun; 65(3):713-720. PubMed ID: 28224361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jeffrey's insights: Jeffrey Modell Foundation's global genetic sequencing pilot program to identify specific primary immunodeficiency defects to optimize disease management and treatment.
    Quinn J; Modell V; Holle J; Truty R; Aradhya S; Johnson B; Orange J; Modell F
    Immunol Res; 2020 Jun; 68(3):126-134. PubMed ID: 32462469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From genotype to phenotype. Further studies measuring the impact of a Physician Education and Public Awareness Campaign on early diagnosis and management of primary immunodeficiencies.
    Modell F; Puente D; Modell V
    Immunol Res; 2009; 44(1-3):132-49. PubMed ID: 19140027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global Expansion of Jeffrey's Insights: Jeffrey Modell Foundation's Genetic Sequencing Program for Primary Immunodeficiency.
    Quinn J; Modell V; Johnson B; Poll S; Aradhya S; Orange JS; Modell F
    Front Immunol; 2022; 13():906540. PubMed ID: 35757720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The case for severe combined immunodeficiency (SCID) and T cell lymphopenia newborn screening: saving lives…one at a time.
    Quinn J; Orange JS; Modell V; Modell F
    Immunol Res; 2020 Feb; 68(1):48-53. PubMed ID: 32128663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary immunodeficiencies in Central and Eastern Europe-the power of networking Report on the activity of the Jeffrey Modell Foundation Centers Network in Central and Eastern Europe.
    Sediva A; Bataneant M; Belevtsev M; Blaziene A; Ciznar P; Förster-Waldl E; Kelecic J; Marodi J; Naumova E; Nasrullayeva G; Ress K; Serban M; Sitkauskiene B; Toth B; Modell V; Modell F; Tenembaum V; Marković M; Avcin T
    Immunol Res; 2019 Oct; 67(4-5):358-367. PubMed ID: 31515711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation.
    Modell V; Gee B; Lewis DB; Orange JS; Roifman CM; Routes JM; Sorensen RU; Notarangelo LD; Modell F
    Immunol Res; 2011 Oct; 51(1):61-70. PubMed ID: 21935653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The four most common pediatric immunodeficiencies.
    Stiehm RE
    Adv Exp Med Biol; 2007; 601():15-26. PubMed ID: 17712988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders.
    Lindegren ML; Kobrynski L; Rasmussen SA; Moore CA; Grosse SD; Vanderford ML; Spira TJ; McDougal JS; Vogt RF; Hannon WH; Kalman LV; Chen B; Mattson M; Baker TG; Khoury M
    MMWR Recomm Rep; 2004 Jan; 53(RR-1):1-29. PubMed ID: 14724556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis and decision tool to measure cost benefit of newborn screening for severe combined immunodeficiency (SCID) and related T-cell lymphopenia.
    Modell V; Knaus M; Modell F
    Immunol Res; 2014 Oct; 60(1):145-52. PubMed ID: 24599744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Duesseldorf warning signs for primary immunodeficiency: is it time to change the rules?
    Lankisch P; Schiffner J; Ghosh S; Babor F; Borkhardt A; Laws HJ
    J Clin Immunol; 2015 Apr; 35(3):273-9. PubMed ID: 25749910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the 10 Warning Signs in Primary and Secondary Immunodeficient Patients.
    Eldeniz FC; Gul Y; Yorulmaz A; Guner SN; Keles S; Reisli I
    Front Immunol; 2022; 13():900055. PubMed ID: 35634313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a physician education and patient awareness campaign on the diagnosis and management of primary immunodeficiencies.
    Pickett D; Modell V; Leighton I; Modell F
    Immunol Res; 2008; 40(1):93-4. PubMed ID: 18058072
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of physician education and public awareness on early diagnosis of primary immunodeficiencies: Robert A. Good Immunology Symposium.
    Modell V
    Immunol Res; 2007; 38(1-3):43-7. PubMed ID: 17917007
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary Immunodeficiency Diseases in Saudi Arabia: a Tertiary Care Hospital Experience over a Period of Three Years (2010-2013).
    Al-Saud B; Al-Mousa H; Al Gazlan S; Al-Ghonaium A; Arnaout R; Al-Seraihy A; Elshorbagi S; Elsayed N; Afzal J; Al-Dhekri H; Al-Muhsen S
    J Clin Immunol; 2015 Oct; 35(7):651-60. PubMed ID: 26395454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "The State of the Union": Current and Future Perspectives on Patient-Centric Care for Primary Immunodeficiencies and Immune Dysregulatory Diseases.
    Hartog NL; Williams KW; Abraham RS
    Front Immunol; 2019; 10():1783. PubMed ID: 31402922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.